Drug Profile
Research programme: cardiovascular disorder therapeutics - Ascelegen Therapeutics
Alternative Names: GDF11-related therapies - Ascelegen Therapeutics; Growth differentiation factor 11-related therapies - Ascelegen Therapeutics; Growth factor-related therapies - Ascelegen TherapeuticsLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Ascelegen Therapeutics
- Class
- Mechanism of Action Growth differentiation factor 11 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Cardiovascular-disorders in USA
- 19 Jun 2014 Early research in Cardiovascular disorders in USA (unspecified route)